Skip to main content
. Author manuscript; available in PMC: 2018 May 7.
Published in final edited form as: Int J Cancer. 2017 Feb 14;140(9):2023–2031. doi: 10.1002/ijc.30630

Table 3.

Pooled multivariate hazard ratio (HR) of site-specific SCC and melanoma by total niacin intake in the NHS and HPFS

Quintile of total niacin intake p for
trend
1 2 3 4 5
Pooled risk on the body sites with higher sun exposure (head, neck, and extremities)
SCC
No. of cases 380 403 394 430 397
Pooled HR1 1 (referent) 0.92 (0.69, 1.23) 0.87 (0.71, 1.05) 0.95 (0.70, 1.29) 0.85 (0.73, 0.98) 0.10
Melanoma
No. of cases 93 106 93 104 115
Pooled HR1 1 (referent) 0.96 (0.72, 1.27) 0.89 (0.48, 1.65) 0.94 (0.71, 1.25) 1.05 (0.77, 1.42) 0.38
Risk of SCC on the body sites with lower sun exposure (trunk and mucosa)
SCC
No. of cases 55 59 63 62 68
Pooled HR1 1 (referent) 0.88 (0.61, 1.28) 0.90 (0.62, 1.31) 0.88 (0.49, 1.58) 0.97 (0.68, 1.40) 0.75
Melanoma
No. of cases 57 71 68 54 76
Pooled HR1 1 (referent) 1.12 (0.74, 1.70) 1.08 (0.67, 1.74) 0.85 (0.58, 1.25) 1.21 (0.63, 2.34) 0.50
1

The multivariate-adjusted HR from each cohort were combined with meta-analytic methods using random effects model. The HR from each cohorts were adjusted for family history of melanoma (yes vs. no), natural hair color (red, blonde, light brown, dark brown and black), number of arm moles (0, 1–2, 3–9 and ≥10), skin reaction to sun exposure as a child/adolescent (none/some redness, burn, painful burn/blisters), number of lifetime blistering sunburns (0, 1–4, 5–9 and ≥10), average time spent in direct sunlight since high school (<2, 2–5, 6–9 and ≥10 hr/wk), cumulative UV flux since baseline (quintiles), body mass index (<25.0, 25.0–29.9, 30.0–34.9 and ≥35.0 kg/m2), physical activity (quintiles), smoking status (never, past, current with 1–14, 15–24 and or ≥25 cigarettes/d), intakes of total energy (quintiles), alcohol (0, 0.1–4.9, 5.0–9.9, 10.0–19.9 and ≥20.0 g/d) and citrus intake (quintiles). Analyses for women were also adjusted for menopausal status and postmenopausal hormone use (premenopausal, postmenopausal never, past or current use.